NewCardio Operating Cycle from 2010 to 2026

NWCI Stock  USD 0.0001  0.00  0.00%   
NewCardio's Operating Cycle is decreasing with very volatile movements from year to year. Operating Cycle is predicted to flatten to 40.43. For the period between 2010 and 2026, NewCardio, Operating Cycle quarterly trend regression had mean deviation of  4.56 and range of 20.5926. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
54.76
Current Value
40.43
Quarterly Volatility
6.83382423
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check NewCardio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NewCardio's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 5.6 M, as well as many indicators such as Price To Sales Ratio of 89.26, Dividend Yield of 0.0 or Days Sales Outstanding of 40.43. NewCardio financial statements analysis is a perfect complement when working with NewCardio Valuation or Volatility modules.
  
Build AI portfolio with NewCardio Stock
Check out the analysis of NewCardio Correlation against competitors.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.
The Operating Cycle trend for NewCardio offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether NewCardio is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest NewCardio's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of NewCardio over the last few years. It is NewCardio's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NewCardio's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Very volatile
   Operating Cycle   
       Timeline  

NewCardio Operating Cycle Regression Statistics

Arithmetic Mean58.07
Geometric Mean57.61
Coefficient Of Variation11.77
Mean Deviation4.56
Median60.84
Standard Deviation6.83
Sample Variance46.70
Range20.5926
R-Value(0.07)
Mean Square Error49.54
R-Squared0.01
Significance0.78
Slope(0.10)
Total Sum of Squares747.22

NewCardio Operating Cycle History

2026 40.43
2025 54.76
2011 60.84
2010 40.25

About NewCardio Financial Statements

Investors use fundamental indicators, such as NewCardio's Operating Cycle, to determine how well the company is positioned to perform in the future. Although NewCardio's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Operating Cycle 54.76  40.43 

Currently Active Assets on Macroaxis

When determining whether NewCardio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NewCardio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Newcardio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Newcardio Stock:
Check out the analysis of NewCardio Correlation against competitors.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is there potential for Health Care Technology market expansion? Will NewCardio introduce new products? Factors like these will boost the valuation of NewCardio. Anticipated expansion of NewCardio directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about NewCardio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.008
Quarterly Revenue Growth
(0.90)
Return On Assets
(2.24)
Understanding NewCardio requires distinguishing between market price and book value, where the latter reflects NewCardio's accounting equity. The concept of intrinsic value—what NewCardio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push NewCardio's price substantially above or below its fundamental value.
It's important to distinguish between NewCardio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NewCardio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, NewCardio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.